This article discusses the best long-term stocks to considering buying right now.
Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...
In an email to developers this week, Apple indicated that it will begin showing additional ads in App Store search results starting Tuesday, March 3. The extra ads will first appear in the App Store ...
Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, and an expanding late-stage pipeline during the company’s Q4 2025 earnings ...
Netflix launched its cheaper, ad-supported option in late 2022. Its growth is starting to contribute to overall revenue. Co-CEO Greg Peters said during the company's fourth-quarter earnings call this ...
Meta on Wednesday announced it’s expanding ads on Threads to all users globally. The expansion, which starts next week, will be gradual, the company says, noting it may take months for the full ...
Threads now has over 400 million monthly active users. (Dave Adamson / Unsplash) Threads has grown enough for Meta to fully integrate it into its advertising machine. On Wednesday, the company said ...
LLY beats Q4 earnings and sales estimates as Mounjaro and Zepbound surge. Shares jump on stronger-than-expected revenue and EPS outlook for 2026.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Digital marketing commerce online sale concept, Businesswoman using laptop with Ads ...
Disappointing news for iPhone and iPad owners last week, when it emerged that from the start of March, Apple will run more ads in App Store search queries. You may feel that searching for “into the ...
The 'Bugonia' and 'Poor Things' director will bring his surrealist style and visual flair to a campaign for the food delivery app. By Alex Weprin Senior Editor The rest of the spot is being kept under ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The Trump ...